Nurix Therapeutics Presents Data at the American Association for Cancer Research…
<!-- Name:DistributionId Value:8808477 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Degraders
Proxygen gibt Kooperation und Lizenzvereinbarung mit MSD für die Entdeckung und…
<!-- Name:DistributionId Value:8802850 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Selective Estrogen Receptor Degraders Show Promise in Breast Cancer
Results from two clinical trials highlighted how new selective estrogen receptor degraders (SERDs) are…
Preclinical Data from Kymera Therapeutics’ Collaborations Demonstrate Therapeutic…
Activity of STAT3 degrader in preclinical model of cutaneous T-cell lymphoma (CTCL) validates selective STAT3 degradation as a potential therapeutic strategy for STAT3-driven T cell…